Bath & Body Works (NYSE:BBWI) Earns Outperform Rating from Telsey Advisory Group

Bath & Body Works (NYSE:BBWI)‘s stock had its “outperform” rating reissued by equities research analysts at Telsey Advisory Group in a report released on Thursday,Benzinga reports. They presently have a $38.00 price objective on the stock. Telsey Advisory Group’s price objective indicates a potential upside of 72.98% from the stock’s current price.

Other equities research analysts have also issued reports about the stock. Weiss Ratings restated a “hold (c-)” rating on shares of Bath & Body Works in a report on Wednesday, October 8th. Wells Fargo & Company lowered their target price on Bath & Body Works from $44.00 to $33.00 and set an “overweight” rating for the company in a report on Monday, October 27th. Jefferies Financial Group dropped their price target on Bath & Body Works from $32.00 to $28.50 and set a “hold” rating on the stock in a research note on Monday, October 13th. Citigroup cut their price target on Bath & Body Works from $42.00 to $40.00 and set a “buy” rating on the stock in a report on Tuesday, August 19th. Finally, JPMorgan Chase & Co. reiterated a “neutral” rating and set a $26.00 price objective on shares of Bath & Body Works in a report on Monday, October 6th. Ten investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Bath & Body Works has a consensus rating of “Moderate Buy” and an average price target of $38.18.

Bath & Body Works Price Performance

NYSE:BBWI opened at $21.97 on Thursday. The business’s 50-day simple moving average is $25.50 and its 200-day simple moving average is $28.55. Bath & Body Works has a fifty-two week low of $21.71 and a fifty-two week high of $41.87. The stock has a market capitalization of $4.53 billion, a PE ratio of 6.52, a price-to-earnings-growth ratio of 0.86 and a beta of 1.53.

Bath & Body Works (NYSE:BBWI) last posted its earnings results on Thursday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.37. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The business had revenue of $1.55 billion during the quarter, compared to analysts’ expectations of $1.55 billion. During the same period in the prior year, the business earned $0.37 EPS. Bath & Body Works’s revenue for the quarter was down .8% compared to the same quarter last year. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. On average, research analysts expect that Bath & Body Works will post 3.3 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the stock. American Century Companies Inc. lifted its stake in Bath & Body Works by 2,204.1% in the 3rd quarter. American Century Companies Inc. now owns 5,174,370 shares of the company’s stock valued at $133,292,000 after purchasing an additional 4,949,796 shares during the last quarter. Jupiter Asset Management Ltd. raised its stake in Bath & Body Works by 553.2% in the third quarter. Jupiter Asset Management Ltd. now owns 3,714,499 shares of the company’s stock valued at $95,685,000 after buying an additional 3,145,797 shares during the period. AQR Capital Management LLC lifted its position in shares of Bath & Body Works by 267.8% in the first quarter. AQR Capital Management LLC now owns 3,993,173 shares of the company’s stock valued at $121,073,000 after buying an additional 2,907,506 shares during the last quarter. Fuller & Thaler Asset Management Inc. lifted its position in shares of Bath & Body Works by 115.7% in the first quarter. Fuller & Thaler Asset Management Inc. now owns 3,680,104 shares of the company’s stock valued at $111,581,000 after buying an additional 1,973,679 shares during the last quarter. Finally, Norges Bank bought a new position in shares of Bath & Body Works during the 2nd quarter worth approximately $57,746,000. 95.14% of the stock is currently owned by institutional investors.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.